Talquetamab
Janssen
['multiple myeloma', 'janssen']
 j&amp;j's janssen submitted the approval application yesterday. today, it's out with the phase ii data on its next multiple myeloma candidate, received subcutaneously weekly or every two weeks: 
covering the science, people, $ & biotechs behind new drugs @Endpts | klahucik@endpointsnews.com | askin Qs, joggin 26.2 | ?? ?? ?? | XC coach | he/him ??????